Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new release; the Back to Top link has been removed as a minor navigation change.
    Difference
    0.8%
    Check dated 2025-09-14T09:47:14.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.8%
    Check dated 2025-09-07T07:40:13.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    9%
    Check dated 2025-08-31T00:55:07.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.12, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-08-16T19:13:51.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T14:08:34.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.8%
    Check dated 2025-07-26T12:16:50.000Z thumbnail image

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.